InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “ Global Plant-based Expression Systems Market – Trends, Industry Competition Analysis, Revenue, and Forecast to 2030.”
According to the latest research by InsightAce Analytic, the global plant-based expression systems market is expected to record a CAGR of 5.4% during a forecast period. By region, North America dominated the market with a major share in 2021.
Curious about this latest version of report? Obtain Report Details@ https://www.insightaceanalytic.com/report/global-plant-based-expression-systems-market/1292
According to the most recent InsightAce Analytic research, the global plant-based expression systems market is anticipated to grow at a CAGR of 5.4% during the projected period. North America dominated the market by region with a major share in 2021.
Plant-based expression systems for the production of vaccines, antibodies, pharmaceutical proteins, and biosimilars have emerged as a valuable alternative to conventional expression platforms such as yeast, bacterial, and animal cell. The plant expression system produces a protein by transforming a vector carrying an antigen gene into a plant cell and expressing the gene of interest in the plant through a stable or transient transformation system. The transient expression system offers various benefits, including safety, rapid scalability, higher stability of recombinant proteins, consistency of product accumulation and others.
The fundamental aspects driving the growth of the plant-based expression systems market include the increasing government funding for the development of plant expression technologies. The market is further driven by growing research activities in protein therapeutics, the high prevalence of chronic and genetic diseases, advancements in protein-engineering technologies, surging demand for protein therapeutics, and the increasing expenditure for drug development.
Advances in plant expression systems allow various pharmaceutical and biopharmaceutical companies to modify and construct innovative, effective and desirable proteins of interest is likely to propel the demand for the plant-based expression systems during the estimated period. For instance, in February 2022, Medicago, a biopharmaceutical company, and GlaxoSmithKline (GSK) received approval for COVIFENZ, COVID-19 vaccine (plant-based virus-like particles [VLP], recombinant, adjuvanted). This vaccine is developed to prevent COVID?19 caused by SARS?CoV?2 in individuals 18 to 64 years of age.
However, the expensive instruments & protein expression reagents and the complex, time-consuming production of recombinant proteins may inhibit the market expansion in the upcoming years.
North America is expected to account for the largest proportion of the plant-based expression systems market during the forecast period, owing to rising demand for protein-based therapies and increased R&D investment for plant expression technologies.
The United States government is the principal supporter of novel plant-based recombinant protein synthesis methods, primarily for the production of influenza vaccines. Apart from this, the Asia-Pacific region is predicted to record rapid growth due to the increasing number of chronic diseases and the high demand for novel vaccines and antibodies.
Major market players operating in the plant-based expression systems market include Medicago, Leaf Expression Systems, Eleva, iBIO, Creative Biogene, PlantForm, Protalix BioTherapeutics, Inc., G+Flas Life Sciences, Kentucky Bioprocessing, and Angany, among others.
Some significant developments in the market:
- In September 2021, Leaf Expression Systems (Leaf) launched SupraVec, Leaf’s new proprietary vector-based expression technology for the rapid production of proteins, vaccines and complex biomolecules within the leaf tissue of plants.
- In January 2021, iBio introduced its FastPharming system, under which plants are used for the transient expression of recombinant proteins at scale, simplifies glycoengineering, and expedites process development. Under the FastPharming system.
For More Information @ https://www.insightaceanalytic.com/report/global-plant-based-expression-systems-market/1292
Global Plant-based Expression Systems Market, by Product, 2022-2030 (Value US$ Mn)
- Cell Therapies
- Gene Therapies
- Monoclonal Antibodies
Global Plant-based Expression Systems Market, by Plant, 2022-2030 (Value US$ Mn)
- Wheat Germ
Global Plant-based Expression Systems Market, by Type of Service, 2022-2030 (Value US$ Mn)
- Research and Development
- Fill / Finish
Global Plant-based Expression Systems Market, by Expression System, 2022-2030 (Value US$ Mn)
- Stable Expression System
- Transient Expression System
Global Plant-based Expression Systems Market, by Region, 2022-2030 (Value US$ Mn)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
North America Plant-based Expression Systems Market, by Country, 2022-2030 (Value US$ Mn)
Europe Plant-based Expression Systems Market, by Country, 2022-2030 (Value US$ Mn)
- Rest of Europe
Asia Pacific Plant-based Expression Systems Market, by Country, 2022-2030 (Value US$ Mn)
- South Korea
- Australia & New Zealand
Latin America Plant-based Expression Systems Market, by Country, 2022-2030 (Value US$ Mn)
- Rest of Latin America
Middle East & Africa Plant-based Expression Systems Market, by Country, 2022-2030 (Value US$ Mn)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Request for ToC/Proposal: https://www.insightaceanalytic.com/request-sample/1292
Why should buy this report:
- To receive a comprehensive analysis of the prospects for the global plant-based expression systems market
- To receive an industry overview and future trends of the plant-based expression systems market
- To analyze the plant-based expression systems market drivers and challenges
- To get information on the plant-based expression systems market size value (US$ Mn) forecast to 2030
- Significant investments, mergers & acquisitions in the plant-based expression systems market industry
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.